A New Triazolothiadiazine Derivative Inhibits Stemness and Induces Cell Death in HCC by Oxidative Stress Dependent JNK Pathway Activation

The authors investigated the cellular bioactivities of a series of triazolothiadiazine derivatives on hepatocellular carcinoma (HCC), which have been previously reported as potent analgesic/anti-inflammatory compounds.